We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Blog

Deciphering RNA to Predict if a Patient Will Respond to a Targeted Drug
Deciphering RNA to Predict if a Patient Will Respond to a Targeted Drug
Blog

We recently spoke to Alif Saleh, CEO of Scipher Medicine to learn how RNA data from a patient’s blood sample can be used to determine the underlying molecular processes driving a disease, and establish how well a patient will respond to a particular therapy.

Read More

Tandem Mass Spectrometry: Rising to Challenges in Clinical Labs
Tandem Mass Spectrometry: Rising to Challenges in Clinical Labs
Blog

Assay sensitivity and specificity continues to be a challenge in measuring hormones at low concentrations. Tandem mass spectrometry offers significant advantages - particularly in a clinical setting, where speed and sensitivity are required. Following SCIEX' launch of a new tandem mass spectrometry system, we spoke with Michael Jarvis, Product Manager at SCIEX, to find out more.

Read More

Combating Neurodegenerative & Age-related Diseases
Combating Neurodegenerative & Age-related Diseases
Blog

We recently spoke to Karoly Nikolich, chairman and chief executive officer of Alkahest, a clinical-stage biotechnology company, to learn more about their approach to developing therapeutics for both neurodegenerative and age-related diseases.

Read More

Immunotherapy Response Prediction in Urothelial Cancer
Immunotherapy Response Prediction in Urothelial Cancer
Blog

While immunotherapy holds great promise for cancer treatment, challenges persist around limited response rate and severe immune-related adverse events. We caught up with Dr. Georg Lautscham, CEO of Protagen, to find out how the prediction of immunotherapy response can be improved for people with urothelial cancer.

Read More

Accelerating the Development of Liver Gene Medicines
Accelerating the Development of Liver Gene Medicines
Blog

Recent technology advancements have enabled the opportunity to increase the efficiency, efficacy and safety of gene and cell-based medicines for a multitude of genetic disorders. To date, a major challenge facing the field has been the ability to deliver therapeutic genes to affected cell types. In this blog, Sarah Haecker Meeks and Michael Roberts from Synpromics outline the ways in which gene medicines can be optimized to overcome this barrier.

Read More

 The Changing Shape of Optofluidics R&D
The Changing Shape of Optofluidics R&D
Blog

Life science businesses are facing growing demand to keep pace in an era of fast-evolving technology. By recognising the potential challenges, a growing number of companies are leveraging the resources and creativity of their suppliers. We took a look at the landscape of optofluidics R&D.

Read More

Developing Therapies to Fight Cancer and Autoimmune Diseases
Developing Therapies to Fight Cancer and Autoimmune Diseases
Blog

We recently spoke to Alexis Peyroles, CEO at OSE Immunotherapeutics to hear more about the findings of their recent study, describing, for the first time ever, the in vivo MOA of interleukin 7 receptor alpha (IL-7Rα) monoclonal antibodies, suggesting therapeutic efficacy in controlling chronic inflammation.

Read More

Candidate Drug Proposes a Botanical Solution to Neuropathic Pain
Candidate Drug Proposes a Botanical Solution to Neuropathic Pain
Blog

NeuroBo Pharmaceuticals’ first lead candidate, NB-01, is positioned as a potential treatment for diabetic neuropathic pain. The candidate, which in 2018 will move into a phase III clinical trial, uses extracts of two species of the plant genus Dioscorea, used in traditional medicine for centuries, but never yet subject to systematic study. We caught up with NeuroBo’s Mark Versavel and Nandan Padukone to find out more.

Read More

Entering the Golden Era of Lateral Flow Diagnostics
Entering the Golden Era of Lateral Flow Diagnostics
Blog

Gold nanorods are increasingly being used in diagnostic applications, such as lateral flow assays. To learn more, we got in touch with Darren Rowles, CEO of Sona Nanotech Inc. who provides insights on diagnostic industry trends, and tells us about the source, application and production process of gold nanoparticles.

Read More

The Liquid Biopsy Trends Transforming Cancer Detection and Treatment
The Liquid Biopsy Trends Transforming Cancer Detection and Treatment
Blog

Liquid biopsy is a less invasive approach compared to traditional surgical biopsies. By collecting a simple blood sample and analyzing circulating tumor DNA (ctDNA), cancer researchers and healthcare professionals can access a myriad of information about a patient’s tumor.

Read More